Advances in Oral Systemic Treatments for Management of Atopic Dermatitis : Episode 5

Opinion

Video

September 23, 2024

Utilizing Long-Term Atopic Dermatitis Data in Clinical Practice

Author(s):

Raj Chovatiya, MD, PhD,George Han, MD, PhD

Medical experts discuss long-term data for other systemic agents in atopic dermatitis and how this information informs their treatment decisions.

EP: 1.JAK Inhibitors and Pathophysiology of Atopic Dermatitis

EP: 2.Oral JAK inhibitors and Their Use for Treatment of Atopic Dermatitis

EP: 3.Oral JAK Inhibitor Use in Atopic Dermatitis: Screening and Monitoring Patients

EP: 4.Long-term Safety Data for JAK Inhibitors in Atopic Dermatitis

EP: 5.Utilizing Long-Term Atopic Dermatitis Data in Clinical Practice

EP: 6.Data on Early Itch Relief with JAK Inhibitors in Atopic Dermatitis

EP: 7.Speed of Itch Relief in Atopic Dermatitis

EP: 8.Systemic Treatments and Switching Therapy in Atopic Dermatitis

EP: 9.Treatment Expectations and Patient Conversations in Atopic Dermatitis

EP: 10.Switching from Biologics to JAK Inhibitors in Atopic Dermatitis: Clinical Data

EP: 11.Treatment Breaks and Rescue Treatments in Atopic Dermatitis

EP: 12.Switching patients to JAK Inhibitors in Atopic Dermatitis in Clinical Practice

EP: 13.Treatment Flexibility While on Abrocitinib in Atopic Dermatitis (JADE REGIMEN)

EP: 14.Future Outlook for Atopic Dermatitis Treatments

Video content above is prompted by the following:

Please share long-term data with other systemic agents in atopic dermatitis and how you use these data to make treatment decisions

Related Videos

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Stephen Nicholls, MBBS, PhD | Credit: Monash University

Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology

Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University

Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s

4 experts are featured in this series.

4 experts are featured in this series.

A. Sidney Barritt, MD | Credit: UNC School of Medicine

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.